Last updated at 04 Jul 2024 12:09 AM
Director
DIN: 08625115
Abdul Rehman is currently associated with 3 companies in various capacities such as Designated Partner, Director and Individual Promoter. They serve as a Director at DERIVE HEALTHCARE SOLUTIONS LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08625115.Abdul Rehman has previously been associated with 1 company in roles such as Partner.Abdul Rehman is currently involved in 3 different roles. Their most recent position is with JORICK ENTERPRISES LLP as a Designated Partner. The first company Abdul Rehman was appointed to as a director was DERIVE HEALTHCARE SOLUTIONS LLP. Abdul Rehman is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Abdul Rehman is currently associated with 3 companies in various capacities such as Designated Partner, Director and Individual Promoter. They serve as a Director at DERIVE HEALTHCARE SOLUTIONS LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08625115.Abdul Rehman has previously been associated with 1 company in roles such as Partner.Abdul Rehman is currently involved in 3 different roles. Their most recent position is with JORICK ENTERPRISES LLP as a Designated Partner. The first company Abdul Rehman was appointed to as a director was DERIVE HEALTHCARE SOLUTIONS LLP. Abdul Rehman is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Male
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (2)
Past Companies (1)
1y 4m 8 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| HEALTH MAVENS PRIVATE LIMITED | Director | 24-May-2022 |
| HEALTH MAVENS PRIVATE LIMITED | Individual Promoter | 24-May-2022 |